U.S. markets close in 40 minutes

RAPT Therapeutics, Inc. (RAPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
17.92-0.81 (-4.32%)
As of 3:14PM EST. Market open.
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
Total Revenue
935
0
0
0
Operating Expense
48,057
43,629
36,947
29,331
Operating Income
-47,122
-43,629
-36,947
-29,331
Other Income Expense
1,071
1,292
800
216
Pretax Income
-46,051
-42,337
-36,147
-29,115
Tax Provision
897
660
-
-
Net Income Common Stockholders
-46,948
-42,997
-36,147
-29,115
Diluted NI Available to Com Stockholders
-46,948
-42,997
-36,147
-29,115
Basic EPS
-
-0.0099
-0.0025
-0.002
Diluted EPS
-
-0.0099
-0.0025
-0.002
Basic Average Shares
-
4,346
14,461
14,461
Diluted Average Shares
-
4,346
14,461
14,461
Total Operating Income as Reported
-47,122
-43,629
-36,947
-29,331
Total Expenses
48,057
43,629
36,947
29,331
Net Income from Continuing & Discontinued Operation
-46,948
-42,997
-36,147
-29,115
Normalized Income
-46,948
-42,997
-36,147
-29,115
EBIT
-47,122
-43,629
-36,947
-29,331
EBITDA
-45,924
-
-
-
Reconciled Depreciation
1,198
1,330
1,237
1,384
Net Income from Continuing Operation Net Minority Interest
-46,948
-42,997
-36,147
-29,115
Normalized EBITDA
-45,924
-42,299
-35,710
-27,947
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0

Premium access required.

Learn more